INTRODUCTION
Historically, the diagnosis and treatment of M. tuberculosis has been difficult, because of its peculiarities; it has a high concentration of lipids in the cell wall, which makes it impermeable to stains and dyes, requiring special staining techniques for microscopic observation, resistant to many antibiotics, resistant to osmotic lysis via complement deposition, as well as resistant to lethal oxidation and survival inside macrophages, making it possible to undergo a long period of latency. Unlike many pathogenic bacteria, M. tuberculosis also grows slowly, making culture and susceptibility testing time consuming. This write-up examines the critical role of the clinical microbiology laboratory, through the various modalities of laboratory diagnosis ,strain-typing and susceptibility testing, with emphasis on the advantages and drawback of these techniques.
ROLE OF THE MEDICAL MICROBIOLOGY LABORATORY
The laboratory physicians have been on the front line in the fight against tuberculosis (TB) ever since Dr Robert Koch announce his discovering of the tuberculus bacillus in 1882. Driven by the worldwide increase in the incidence of tuberculosis, several changes in laboratory practice have evolved over the past several years. The challenge for the clinical laboratory is to provide the most rapid and reliable technologies for diagnosis and antimycobacterial drug susceptibility, as well as speciation and strain-typing, possibly within days or even hours rather than weeks. 
MODALITIES OF LABORATORY

Urine:
Urine specimen may be useful in the diagnosis of renal tuberculosis. At least three early morning urine specimens should be collected on successive 24-hour periods to maximize the chance of recovery of mycobacterium.
SAFETY CONSIDERATIONS
Generally, Mycobacterium tuberculosis is highly hazardous,stringent safety control standards conforming to the Biosafety Level 3 (BSL 3) with a Biosafety Cabinet 2(BSC 2) and possibly a dedicated laboratory is required for specimen processing 5 . Advantages: BACTEC method can be read less than 7 days of incubation, averages 9-14 days. There is also an increase in the yield of positive cultures from clinical specimens compared with conventional solid media 10 . It can be adapted for antimicrobial sensitivity testing 11 . Limitations: It cannot be used for colonial morphology in organism identification, cost of instrumentation and the need for disposal of radioactive material BACTEK
1) Microscopy
MYCOBACTERIA GROWTH INDEX TUBE (MGIT)
The MGIT is a nonradiometric, flourescence, manual or automated system for the rapid detection of mycobacterium species from various sites of the body. It consist of a glass tube with modified 7H12 broth base, enriched with basic nutrients for growth of mycobacteria and a mixture of antibiotics to inhibit the growth of contaminating bacteria. A flourescent compound is embedded at the bottom of the tube. The flourescent compound does not flourence in the presence of oxygen, but following depletion of oxygen as a result of mycobacteria growth there is flourescence which can be detected visually under ultraviolet light. In the automated version (MGIT 960 system), flourescence is detected by a sensor. The system holds 960 tubes which are continuously monitored.
LYSIS-CENTRIFUGATION BLOOD CULTURE SYSTEM
The recovery of mycobacterium from peripheral blood and bone marrow samples may be improved by releasing the intracellular mycobacterial cells into the blood culture broth, increasing the rate and reducing the time of recovery. In the lysis-centrifugation blood culture method, blood is put into a tube containing an anticoagulant and a lysing agent to effect rupture of both erythrocytes and neutrophils. Following centrifugation of the tube, the sediment is inoculated into the appropriate culture media. This method has increased both the yield and shortened the time of recovery of mycobacteria from blood cultures 12, 13 . 
PHAGE AMPLIFICATION TECHNIQUE (PAT)
False Negative Results:
This may result from conditions such as anergy which is the lack of the body's defence mechanisms when it comes into contact with foreign substances. eg AIDS and also in overwhelming TB when the immune response has waned considerably.
BCG AND TUBERCULIN TEST
There is disagreement on the use of tuberculin test on people who have been immunized with BCG. The US recommendation is that previous BCG should be ignored, while in the UK, the recommendation is that interferon tests should be used to help interpret positive tuberculin test. The US approach is likely to lead to more false positive and more unnecessary treatment with potentially toxic drugs.
INTERFERON-GAMMA RELEASE ASSAYS (IGRA)
Because of the difficulties with the tuberculin test interpretation, the interferon-gamma assay test was developed. This test is used in all circumstances in which tuberculin test is currently being used such as contact investigations, evaluation of recent immigrants who have had BCG vaccination, TB screening of health care workers etc. Two available formats of the interferon-gamma release assays are; the Quantiferon-TB Gold and T Spot-TB test. The IGRA assay is based on the ability of the Mycobacterium tuberculosis antigens, which includes the Early Secretory Antigen Target 6 (ESAT-6) and Culture Filtrate Protein 10 (CFP-10) to stimulate host production of interferon -gamma. Because these antigens are not present in NTM or in BCG vaccine, these tests can distinguish latent tuberculosis infection from BCG immunization. The Quantiferon-TB Gold was approved by the US Food and Drug Administration (FDA) in 2005. This is a whole blood test. Blood samples are mixed with synthetic peptides of ESAT-6 and CFP-10 and incubated for 16-24 hrs, the amount of interferongamma released by the lymphocytes is detected by enzyme immunoassay. The T Spot-TB test uses a different method of detecting interferon-gamma from peripheral mononuclear cells. In T Spot-TB assay, T-cells releasing interferon-gamma to ESAT-6 and CFP-10 are detected and quantified as spot -forming cells. Numerous studies that have been conducted throughout the world using these methods show higher specificity and better correlation with exposure to M. tuberculosis [15] [16] [17] [18] [19] 
BIOCHEMICAL TESTS
These are batteries of tests that are based on the enzymatic and metabolic characteristics of the bacteria in terms of nutrient requirements and utilization as well as their metabolic products. For example MTB complex can be differentiated from the NTM by the following characteristics; buff colony on solid media, slow growth rate, Lack of pigment, reduction of nitrate, production of niacin and a positive catalase test which is inactivated at 68 0 C.
CHROMATOGRAPHY
This technique is based on the difference in length of mycolic acid residue on the cell wall of different species. It is used for speciation following isolation by cultural techniques. This technique is used in reference laboratories for epidemiologic studies. Chromatographic techniques have changed as technology has evolved. Earlier methods such as column chromatography and thin layer chromatography have been replaced by gas chromatography and most recently by high pressure liquid chromatography (HPLC).Chromatography is rapid, a total time of 2 hours is required. It is highly reproducible, and as little as a loopful of organism is required 27 . The draw back of this technique is the initial cost of equipment which is high.
The use of negative-ion mass spectrometry to detect tuberculostearic acid in clinical specimens is also gaining ground and hold promise for the rapid detection of mycobacteria 28 .
GENOTYPING
This is an essential tool in the laboratory for TB epidemiology. Genotyping relies on molecular techniques based on PCR. New PCRbased genotyping methods include Spacer Oligonucleotide Typing (Spoligotyping) and Mycobacterial Interspersed Repetitive Unit (MIRU) typing. Spoligotyping is based on differences between strains in the spacer sequences in the direct repeat locus of the M. tuberculosis genome. MIRU is based on variable numbers of tandem repeat at 12 loci in the genome of M. tuberculosis 29 . These genotyping techniques can provide typing information from culture within a month from the time the specimen is collected from patient. Genotyping is useful in answering specific question related to suspected outbreak of TB in institutions such as hospitals schools and prisons. PCR based strain-typing requires only a small cell mass and yield numerical results that can be compared easily either within a laboratory or between laboratories to determine whether two strains are the same. When used together for strain typing, spoligotyping and MIRU provide a powerful combination of tools that can discriminate strains which are not part of the chain of transmission 21 . Rarely, however, unrelated strain could have the same spoligotyping and MIRU number 21 . This limitation has given rise to DNA fingerprinting DNA fingerprinting DNA fingerprinting based on restriction fragment length polymorphism (RFLP) is the gold standard for strain-typing in mycobacteriology.
The insertion sequence IS6110 was specifically identified as the target of DNA probe to be used in fingerprint analysis 30, 31 . It requires a week for the assay to be performed and results evaluated. 
PHENOTYPIC METHODS:
These methods include proportional methods, the radiometric method, and modified phage amplification technique. In the proportional method, the mycobacteria isolate is incubated on two similar agar slope of Middlebrook 7H10. One of these contain a recommended concentration of antimycobacteria and the other free of the drug. This will require extra 2 weeks or more from the isolation of the organism. Interpretation is based on a standard proportion method which is the number of organisms resistant to each drug concentration as a percentage of the number of organism growing on the drug free media. Drug routinely tested are streptomycin, isoniazid, rifampicin and ethambutol. In the BACTEC Radiometric method, a standardized innoculum is inoculated into a drug free and a drug containing vial. The amounts and rates of CO2 produced in the absence and presence of the drug are compared to determine susceptibility or resistance. The BACTEC radiometric method would require extra 2 to 3 weeks from isolation. The BACTEK MGIT 960 and BACTEK 460 are currently the only methods currently cleared for use in the USA
11
. Susceptibility tests should be carried out in all initial isolates of M tuberculosis and on isolates from patients who remain culture-positive after 3 months or demonstrate clinical evidence of therapeutic failure 11 . In the modified phage amplification technique, the antimicrobial tested for is incorporated into the medium inoculated with the mycobacterium isolate, while the second medium is similarly inoculated without the drug. Growth comparison is made after incubation for 2 days.
GENOTYPIC METHODS
These entail molecular techniques aimed at detecting genes that code for resistance characteristics. Example includes; DNA probe and DNA sequencing of M. tuberculosis gene such as catalase (katG) or RNA polymerase (rpoB). Mutations in these genes have been associated with resistance to isoniazid and rifampicin respectively 32,33 , the most common drugs used to treat TB. The use of Molecular beacons in a real-time PCR reaction, first described in 2004, can differentiate between the presence of the wild-type sequence associated with drug susceptibility or a mutated sequence associated with drug resistance 34 . Genotypic methods are not routinely used in the mycobacterium laboratory; they are essentially for research purposes
THE FUTURE OF TB DIAGNOSTICS
The rapid technological evolution in the laboratory diagnosis of TB, especially in the application of molecular biology has diminished the time required for identification and susceptibility testing and may eliminate the need for lengthy culture and protracted biochemical methods. With continuous effort at increasing their reproducibility, ease of performance and cost containment, it is hoped that they will soon evolve from reference laboratories into clinical diagnostic laboratories. For now, there is need for integration of services provided by public and private laboratories with tuberculosis-control programmes to provide an effective system for diagnosis, treatment and control of TB 35 . In instances where some of the newer molecular methods are not available, or are not cost effective, as in developing countries, a system must be developed so that testing can be referred, in a timely manner to a reference laboratory. A critical component of such a system will be to assure that results are sent to the appropriate TB-control programmes, as well as to the health-care provider. Development and promotion of this integrated system is a challenge and responsibility of all mycobacteriology staff and public health experts. 
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